CLDX
Celldex Therapeutics·NASDAQ
--
--(--)
--
--(--)
CLDX fundamentals
Celldex Therapeutics (CLDX) released its earnings on Nov 10, 2025: revenue was 0 (YoY -100.00%), missed estimates; EPS was -1.01 (YoY -57.81%), missed estimates.
Revenue / YoY
0
-100.00%
EPS / YoY
-1.01
-57.81%
Report date
Nov 10, 2025
EPS
Actual | -0.73 | -0.5 | -0.36 | -0.55 | -0.42 | -0.34 | -0.45 | -0.43 | -0.49 | -0.77 | -0.57 | -0.56 | -0.62 | -0.65 | -0.81 | -0.83 | -0.56 | -0.54 | -0.64 | -0.71 | -0.81 | -0.85 | -1.01 | ||||||||||
Forecast | -0.71 | -0.58 | -0.36 | -0.3667 | -0.345 | -0.4 | -0.355 | -0.4167 | -0.446 | -0.46 | -0.5667 | -0.59 | -0.622 | -0.6583 | -0.68 | -0.7338 | -0.6929 | -0.5878 | -0.6725 | -0.7374 | -0.755 | -0.8558 | -0.8995 | ||||||||||
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -2.82% | +13.79% | 0.00% | -49.99% | -21.74% | +15.00% | -26.76% | -3.19% | -9.87% | -67.39% | -0.58% | +5.08% | +0.32% | +1.26% | -19.12% | -13.11% | +19.18% | +8.13% | +4.83% | +3.72% | -7.28% | +0.68% | -12.28% |
Revenue
Actual | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 2.73M | 236.00K | 668.00K | 3.79M | 685.00K | 3.48M | 153.00K | 333.00K | 174.00K | 163.00K | 407.00K | 1.61M | 967.00K | 268.00K | 1.52M | 4.13M | 200.00K | 2.50M | 3.19M | 1.18M | 695.00K | 730.00K | 0 |
Forecast | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 990.00K | 800.00K | 395.00K | 600.00K | 965.00K | 643.33K | 1.22M | 1.04M | 560.00K | 400.00K | 360.00K | 264.00K | 410.00K | 528.00K | 583.33K | 1.44M | 809.00K | 854.29K | 835.56K | 1.02M | 997.60K | 1.03M | 985.82K |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +175.56% | -70.50% | +69.11% | +531.00% | -29.02% | +440.93% | -87.48% | -67.86% | -68.93% | -59.25% | +13.06% | +510.98% | +135.85% | -49.24% | +160.06% | +186.66% | -75.28% | +192.41% | +281.90% | +14.71% | -30.33% | -29.09% | -100.00% |
Earnings Call
You can ask Aime
What is the market's earnings forecast for Celldex Therapeutics next quarter?What does Celldex Therapeutics do and what are its main business segments?What factors drove the changes in Celldex Therapeutics's revenue and profit?What were the key takeaways from Celldex Therapeutics's earnings call?What is the revenue and EPS growth rate for Celldex Therapeutics year over year?What guidance did Celldex Therapeutics's management provide for the next earnings period?What is Celldex Therapeutics's latest dividend and current dividend yield?What is Celldex Therapeutics's gross profit margin?
